# Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Clinical trial · Alachua Government Services, Inc.

- Archive id: nct:NCT01773928
- Published: 2013-01-23
- Venue: ClinicalTrials.gov
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT01773928
- Source URL: https://clinicaltrials.gov/study/NCT01773928
- Provenance: clinicaltrials

## Abstract

The purpose of this study is to determine if a Vero cell-derived trivalent seasonal influenza vaccine produced by the modified manufacturing process: 1. induces immune responses comparable to that produced by the current manufacturing process 2. has an acceptable safety profile compared to a licensed trivalent seasonal influenza vaccine 3. demonstrates consistency of immune response among three different lots.

_Abstract reproduced under ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters._

## Trial details

- status: COMPLETED
- phase: PHASE3
- study type: INTERVENTIONAL
- enrollment: 1928
- sponsor: Alachua Government Services, Inc.
- conditions: Influenza
- interventions: BIOLOGICAL: Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing process (VCIV modified); BIOLOGICAL: VCIV manufactured with the current manufacturing process (VCIV current); BIOLOGICAL: Fluzone®, licensed trivalent influenza vaccine (TIV)
- start date: 2013-01-01
- primary completion date: 2013-04-01
- has results: true
- data source: ClinicalTrials.gov
- data processed: 2026-10-29T09:00:05
- modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Topics: [Gene & Cell Therapy](https://space-kitty.com/topics/gene-cell-therapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.